Report cover image

Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges, Dipsticks & Kits), Type (Blood & Serum Creatinine Tests, Urine Tests), End User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 186 Pages
SKU # IRE18418166

Description

Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges, Dipsticks & Kits), Type (Blood & Serum Creatinine Tests, Urine Tests), End User - Global Forecast 2024-2030


The Albumin & Creatinine Tests Market size was estimated at USD 1.47 billion in 2023 and expected to reach USD 1.66 billion in 2024, at a CAGR 13.23% to reach USD 3.52 billion by 2030.

The albumin & creatinine tests market constitutes diagnostic devices, reagents, and services used to measure albumin and creatinine levels in blood or urine samples. These tests are crucial in evaluating kidney function, detecting chronic kidney disease (CKD), diagnosing diabetic nephropathy, and monitoring treatment responses for various renal conditions. The rising prevalence of diabetes mellitus and hypertension, increased awareness regarding preventive healthcare measures and early diagnosis, advancements in biotechnology and biochemical analysis techniques improving test accuracy, and faster results drive market expansion. Additionally, emerging economies with large populations requiring accessible testing options present potential opportunities as governments invest more resources into healthcare infrastructure development. Despite the numerous growth avenues within this sector, certain limitations, including consistency in testing procedures, may lead to inaccuracies in test results hindering clinical decision-making processes concerning patient management. Furthermore, reimbursement issues related to medical insurance policies across countries limit patients' access to advanced testing technologies. Innovative research and development initiatives within the albumin & creatinine tests market are anticipated to generate new opportunities for business growth.

Regional Insights

The Americas region represents a mature landscape for the market, with established medical infrastructures and stringent regulations governing manufacturers and providers. Manufacturers and providers operating in the U.S., and Canada, face strict regulatory guidelines from agencies such as FDA and Health Canada to commercialize the products in the market. In the European Union, countries such as Germany, France, and Italy, along with the UK, have seen increasing demand for albumin & creatinine tests due to rising awareness about kidney diseases coupled with growth in healthcare infrastructure which is driving the market growth in the region. In the APAC region, China, Japan, and India are experiencing rapid economic growth accompanied by improving healthcare facilities that drive demand for better diagnostic tools. The rising prevalence of chronic kidney diseases (CKD), diabetes, and hypertension, as well as increased awareness about early disease detection and monitoring, has significantly boosted the demand for the albumin & creatinine tests market in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Albumin & Creatinine Tests Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Albumin & Creatinine Tests Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Albumin & Creatinine Tests Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Anamol Laboratories Pvt. Ltd., Arbor Assays Inc., ARKRAY, Inc., BTNX Inc., CompareNetworks, Inc., Danaher Corporation, Eagle Biosciences, Inc., F. Hoffmann-La Roche AG, J. Mitra & Co. Pvt. Ltd., Laboratory Corporation of America Holdings, Merck KGaA, Ortho Clinical Diagnostics, Practo Technologies Private Limited, PromoCell GmbH, Randox Laboratories Ltd., Siemens AG, Sysmex Europe SE, Thermo Fisher Scientific Inc., and UJIFILM Wako Pure Chemical Corporation.

Market Segmentation & Coverage

This research report categorizes the Albumin & Creatinine Tests Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

Analyzers
  • Cartridges

    POC Analyzer Cartridges
  • Table-top Analyzer Cartridges
  • Dipsticks & Kits
  • Reagents
  • Type

    Blood & Serum Creatinine Tests
  • Urine Tests

    Glycated Albumin Tests
  • Urine Albumin Tests
  • Urine Creatinine Tests
  • End User

    Diagnostic Laboratories
  • Hospitals & Clinics
  • Research Laboratories & Institutes
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Albumin & Creatinine Tests Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Albumin & Creatinine Tests Market?
    3. What are the technology trends and regulatory frameworks in the Albumin & Creatinine Tests Market?
    4. What is the market share of the leading vendors in the Albumin & Creatinine Tests Market?
    5. Which modes and strategic moves are suitable for entering the Albumin & Creatinine Tests Market?


    Note: PDF & Excel + Online Access - 1 Year

    • Table of Contents

    186 Pages
    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Albumin & Creatinine Tests Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Increasing incidences of chronic kidney disorders
    5.1.1.2. Rising adoption of point-of-care (POC) diagnostics
    5.1.1.3. Growing cases of urinary tract infections
    5.1.2. Restraints
    5.1.2.1. Problems with spot urine sampling and testing
    5.1.3. Opportunities
    5.1.3.1. Emergence of automated systems for overall urine analysis
    5.1.3.2. Introduction of home testing kit coupled with surge in number of pathology laboratory
    5.1.4. Challenges
    5.1.4.1. Concern with the accuracy and limited infrastructure in rural areas
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Albumin & Creatinine Tests Market, by Product
    6.1. Introduction
    6.2. Analyzers
    6.3. Cartridges
    6.4.1. POC Analyzer Cartridges
    6.4.2. Table-top Analyzer Cartridges
    6.4. Dipsticks & Kits
    6.5. Reagents
    7. Albumin & Creatinine Tests Market, by Type
    7.1. Introduction
    7.2. Blood & Serum Creatinine Tests
    7.3. Urine Tests
    7.4.1. Glycated Albumin Tests
    7.4.2. Urine Albumin Tests
    7.4.3. Urine Creatinine Tests
    8. Albumin & Creatinine Tests Market, by End User
    8.1. Introduction
    8.2. Diagnostic Laboratories
    8.3. Hospitals & Clinics
    8.4. Research Laboratories & Institutes
    9. Americas Albumin & Creatinine Tests Market
    9.1. Introduction
    9.2. Argentina
    9.3. Brazil
    9.4. Canada
    9.5. Mexico
    9.6. United States
    10. Asia-Pacific Albumin & Creatinine Tests Market
    10.1. Introduction
    10.2. Australia
    10.3. China
    10.4. India
    10.5. Indonesia
    10.6. Japan
    10.7. Malaysia
    10.8. Philippines
    10.9. Singapore
    10.10. South Korea
    10.11. Taiwan
    10.12. Thailand
    10.13. Vietnam
    11. Europe, Middle East & Africa Albumin & Creatinine Tests Market
    11.1. Introduction
    11.2. Denmark
    11.3. Egypt
    11.4. Finland
    11.5. France
    11.6. Germany
    11.7. Israel
    11.8. Italy
    11.9. Netherlands
    11.10. Nigeria
    11.11. Norway
    11.12. Poland
    11.13. Qatar
    11.14. Russia
    11.15. Saudi Arabia
    11.16. South Africa
    11.17. Spain
    11.18. Sweden
    11.19. Switzerland
    11.20. Turkey
    11.21. United Arab Emirates
    11.22. United Kingdom
    12. Competitive Landscape
    12.1. FPNV Positioning Matrix
    12.2. Market Share Analysis, By Key Player
    12.3. Competitive Scenario Analysis, By Key Player
    12.3.1. Agreement, Collaboration, & Partnership
    12.3.1.1. Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease
    12.3.2. New Product Launch & Enhancement
    12.3.2.1. American Regent Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
    12.3.3. Investment & Funding
    12.3.3.1. Healthy.io Secures USD 50 Million in Series D Funding
    13. Competitive Portfolio
    13.1. Key Company Profiles
    13.1.1. Abbott Laboratories
    13.1.2. Abcam PLC
    13.1.3. Anamol Laboratories Pvt. Ltd.
    13.1.4. Arbor Assays Inc.
    13.1.5. ARKRAY, Inc.
    13.1.6. BTNX Inc.
    13.1.7. CompareNetworks, Inc.
    13.1.8. Danaher Corporation
    13.1.9. Eagle Biosciences, Inc.
    13.1.10. F. Hoffmann-La Roche AG
    13.1.11. J. Mitra & Co. Pvt. Ltd.
    13.1.12. Laboratory Corporation of America Holdings
    13.1.13. Merck KGaA
    13.1.14. Ortho Clinical Diagnostics
    13.1.15. Practo Technologies Private Limited
    13.1.16. PromoCell GmbH
    13.1.17. Randox Laboratories Ltd.
    13.1.18. Siemens AG
    13.1.19. Sysmex Europe SE
    13.1.20. Thermo Fisher Scientific Inc.
    13.1.21. UJIFILM Wako Pure Chemical Corporation
    13.2. Key Product Portfolio
    14. Appendix
    14.1. Discussion Guide
    14.2. License & Pricing
    FIGURE 1. ALBUMIN & CREATININE TESTS MARKET RESEARCH PROCESS
    FIGURE 2. ALBUMIN & CREATININE TESTS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ALBUMIN & CREATININE TESTS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ALBUMIN & CREATININE TESTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ALBUMIN & CREATININE TESTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ALBUMIN & CREATININE TESTS MARKET DYNAMICS
    FIGURE 7. ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
    FIGURE 8. ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    FIGURE 10. ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
    FIGURE 12. ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 14. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 16. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. ALBUMIN & CREATININE TESTS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 22. ALBUMIN & CREATININE TESTS MARKET SHARE, BY KEY PLAYER, 2023

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us